© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
July 31, 2021
The panel provides their final thoughts on the treatment of asthma and what they see and hope for in the future.
A discussion on the future of emerging therapies and whether they will have an impact on improving lung function in patients with severe asthma.
July 25, 2021
Sidney Braman, MD, and Geoffrey Chupp, MD, discuss other novel agents currently in clinical trials for the treatment of severe asthma.
Geoffrey Chupp, MD, and Nicola Hanania, MD, MS, review the phase 2 PATHWAY trial and the phase 3 NAVIGATOR trial details for tezepelumab in patients with severe, oral corticosteroid-dependent asthma.